Subscribe To
Universal health (uhs) cuts guidance, falls 6.1%: what's ahead?
Universal Health's (UHS) acute care hospitals experience lower-than-expected patient volumes in the sec...
July 1, 2022, 5:46 pm
Anebulo pharmaceuticals to announce topline data for aneb-001 from an ongoing phase 2 clinical trial for acute cannabinoid intoxication on tuesday july 5, 2022
AUSTIN, Texas--(BUSINESS WIRE)--Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions fo...
June 23, 2022, 4:00 pm
Invacare corporation to present at the 12th annual east coast ideas investor conference
ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC), a leading manufacturer and distributor of medical equipment used in non-...
June 7, 2022, 9:22 am
Abbott reopens baby formula plant in michigan
Abbott Laboratories said on Saturday that it has reopened its baby formula production plant in Sturgis, Michigan, taking a step toward alleviating an ...
June 4, 2022, 11:58 am
Revive therapeutics to advance its drug pipeline for inflammatory liver disorders amid growing cases of acute hepatitis in children
Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) has announced plans to advance its drug pipeline for inflammatory liver disorders in light of the growi...
May 31, 2022, 8:43 am
Viemed healthcare to host investor webcast
LAFAYETTE, La., May 26, 2022 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a home medic...
May 26, 2022, 6:15 pm
Fda places clinical hold on foghorn therapeutics' early-stage blood cancer trial
The FDA has instituted a clinical hold on Foghorn Therapeutics Inc's (NASDAQ: FHTX) Phase 1 dose-escalation study of FHD-286 in relapsed and/or re...
May 20, 2022, 6:38 am
Aim immunotech to file investigational new drug application for ampligen to treat long covid
AIM ImmunoTech Inc (NYSE:AIM) has announced that it is working towards filing an Investigational New Drug (IND) application with the US Food and Drug ...
May 18, 2022, 9:01 am
Why pfizer stock is anything but a safe bet for investors
Pfizer Inc. (NYSE:PFE) is on the spotlight, after announcing the European Commission granted marketing authorization for VYDURA, the first medicine ap...
April 28, 2022, 4:11 pm
Nkarta's stock jumps 42% after announcing positive phase 1 data for experimental car-t therapies
Shares of Nkarta Inc. NKTX, -2.51% soared 42.7% in premarket trading on Monday after the company reported positive Phase 1 clinical data for two exper...
April 25, 2022, 8:04 am
Vor bio to present at keystone symposia precision genome engineering meeting
Presentations showcase breadth of Vor Bio's multiplex editing capability including base editing of human hematopoietic stem and progenitor cells (HSPC...
April 25, 2022, 8:00 am
Rail regulators want to speed emergency service responses
The Surface Transportation Board has issued a notice of proposed rulemaking that would modify existing emergency service rules so the board could “a...
April 23, 2022, 11:56 am
Fda approves biocardia's phase 1 trial with cell therapy in covid-19, shares jump
The FDA has signed off BioCardia Inc's (NASDAQ: BCDA) Investigational New Drug (IND) application for BCDA-04 to initiate Phase 1/2 trial in adult p...
April 12, 2022, 9:32 am
Veru's stock nearly triples as covid-19 drugs cuts reduces deaths by 55% in hospitalized patients
Veru Inc (NASDAQ: VERU) has announced positive efficacy and safety results from a planned interim analysis of Phase 3 COVID-19 trial evaluating ora...
April 11, 2022, 12:10 pm
Gracell biotechnologies to present data at aacr annual meeting 2022 showcasing early first-in-human results for gc502 in r/r b-all
Allogeneic, off-the-shelf CAR-T therapy with CD19/CD7 dual-directed CAR shows promising early results in patients with r/r B-ALL PALO ALTO, Calif. and...
April 8, 2022, 4:00 pm
Emmaus life sciences presents positive study data on endari treatment in sickle cell patients
Emmaus Life Sciences Inc (OTCQX:EMMA) has announced real-world data on the company's prescription-grade L-glutamine oral powder, Endari, in prevent...
April 7, 2022, 10:06 am
Why erytech pharma shares are rising today
Erytech Pharma SA (NASDAQ: ERYP) says that the results from the NOPHO sponsored Phase 2 trial of eryaspase in ...
April 7, 2022, 8:15 am
Baxter's (bax) st set receives fda nod, to boost patient outcome
Baxter's (BAX) ST Set is expected to improve treatments in an acute care environment....
April 6, 2022, 12:48 pm
Why bioxcel therapeutics stock is surging today
BioXcel Therapeutics Inc (NASDAQ: BTAI) shares are trading higher Wednesday after the company announced that the U.S. Food and Drug Administration app...
April 6, 2022, 9:22 am
Precigen (pgen) up on fda fast track tag for car-t candidate
Precigen (PGEN) is developing CAR T therapy candidate, PRGN-3006 UltraCAR-T, for treating acute myeloid...
April 5, 2022, 10:32 am